|
Jun 11
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
|
May 27
|
2 Value Stocks with Exciting Potential and 1 to Steer Clear Of
|
|
May 27
|
Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1
|
|
May 26
|
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
|
|
May 22
|
Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More
|
|
May 22
|
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
|
|
Apr 18
|
Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
|
|
Apr 17
|
Bristol Myers Squibb (BMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Apr 17
|
BioMarin to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 4:30pm ET
|
|
Apr 16
|
BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Q1 Release
|
|
Apr 16
|
Legend Biotech (LEGN) Moves 5.1% Higher: Will This Strength Last?
|
|
Apr 16
|
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks
|
|
Apr 11
|
6 Stocks With Clear Price Dislocations That I Purchased During Wall Street's Historic Volatility
|
|
Apr 10
|
Will BioMarin (BMRN) Beat Estimates Again in Its Next Earnings Report?
|
|
Apr 10
|
Strength Seen in BioMarin (BMRN): Can Its 6.3% Jump Turn into More Strength?
|
|
Apr 10
|
Astronics and Boston Beer have been highlighted as Zacks Bull and Bear of the Day
|
|
Feb 13
|
SpringWorks Therapeutics (SWTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Feb 13
|
Unveiling BioMarin (BMRN) Q4 Outlook: Wall Street Estimates for Key Metrics
|
|
Feb 12
|
BMRN vs. CSLLY: Which Stock Is the Better Value Option?
|
|
Feb 12
|
BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|